EVITAROL is formulated with actives that are based on a derivative used in other countries: most specifically, India. With these countrys’ prophylactic approach to Covid a reduction in infection rates are reduced. A comparative perspective shows, most recent figures as of January 11th 2022: 

 

US reports 187,630 total cases per million population with 2,579 deaths per million of the population.

 

Canada reports 67,857 cases per million of population with a total of  807 deaths per million of the population.

 

India reports 25,613 cases per million of population with a total of  346 deaths per million of the population.

​

 

As previously published, India have reported using a homeopathic remedy with ingredients similar to EVITAROL as an approach to managing COVID 19. The numbers in comparison to other countries show a greater less per population infection rate. We have investigated the findings, and created an immune system based, respiratory infection focused, antibody resistant compounded formula of identifiably proven ingredients to create a novel remedy to approach the virus and similar respiratory infection. 

 

This is EVITAROL.

​